Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:OM NASDAQ:SKIN NASDAQ:TLSI NASDAQ:VANI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeOMOutset Medical$13.54-4.6%$15.80$5.85▼$25.35$252.10M2.13154,664 shs136,200 shsSKINBeauty Health$2.30-5.7%$1.98$0.78▼$2.56$309.45M1.23874,453 shs1.35 million shsTLSITriSalus Life Sciences$4.73-3.5%$4.67$3.42▼$5.88$244.35M0.49105,758 shs77,687 shsVANIVivani Medical$1.22-4.7%$1.34$0.91▼$1.80$75.83M3.1253,379 shs89,631 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceOMOutset Medical-4.58%-1.67%+8.93%-33.23%+78.82%SKINBeauty Health-5.74%+15.00%+4.07%+47.44%+54.36%TLSITriSalus Life Sciences-3.47%-5.02%+32.49%-14.00%-5.21%VANIVivani Medical-4.69%+5.17%-3.17%+2.52%-5.43%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeOMOutset Medical$13.54-4.6%$15.80$5.85▼$25.35$252.10M2.13154,664 shs136,200 shsSKINBeauty Health$2.30-5.7%$1.98$0.78▼$2.56$309.45M1.23874,453 shs1.35 million shsTLSITriSalus Life Sciences$4.73-3.5%$4.67$3.42▼$5.88$244.35M0.49105,758 shs77,687 shsVANIVivani Medical$1.22-4.7%$1.34$0.91▼$1.80$75.83M3.1253,379 shs89,631 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceOMOutset Medical-4.58%-1.67%+8.93%-33.23%+78.82%SKINBeauty Health-5.74%+15.00%+4.07%+47.44%+54.36%TLSITriSalus Life Sciences-3.47%-5.02%+32.49%-14.00%-5.21%VANIVivani Medical-4.69%+5.17%-3.17%+2.52%-5.43%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceOMOutset Medical 3.00Buy$24.6782.18% UpsideSKINBeauty Health 2.00Hold$2.6314.13% UpsideTLSITriSalus Life Sciences 3.25Buy$10.75127.27% UpsideVANIVivani Medical 3.00Buy$4.00227.87% UpsideCurrent Analyst Ratings BreakdownLatest VANI, SKIN, TLSI, and OM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/2/2025VANIVivani MedicalHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$4.008/19/2025OMOutset MedicalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSector Perform$22.008/7/2025OMOutset MedicalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Perform$21.00 ➝ $22.008/1/2025SKINBeauty HealthStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$3.00 ➝ $4.007/14/2025OMOutset MedicalBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$37.00(Data available from 9/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookOMOutset Medical$113.69M2.12N/AN/A$7.49 per share1.81SKINBeauty Health$334.30M0.87$0.06 per share38.59$0.41 per share5.61TLSITriSalus Life Sciences$29.43M8.02N/AN/A($0.83) per share-5.70VANIVivani MedicalN/AN/AN/AN/A$0.30 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateOMOutset Medical-$127.98M-$20.29N/A∞N/A-82.06%-97.17%-32.84%11/5/2025 (Estimated)SKINBeauty Health-$29.10M-$0.28N/AN/AN/A-6.13%-32.82%-2.96%11/11/2025 (Estimated)TLSITriSalus Life Sciences-$30.05M-$1.18N/AN/AN/A-86.61%N/A-116.50%11/13/2025 (Estimated)VANIVivani Medical-$23.49M-$0.45N/AN/AN/AN/A-194.66%-68.64%11/12/2025 (Estimated)Latest VANI, SKIN, TLSI, and OM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025VANIVivani Medical-$0.10-$0.12-$0.02-$0.12N/AN/A8/12/2025Q2 2025TLSITriSalus Life Sciences-$0.22-$0.27-$0.05-$0.27$10.69 million$11.21 million8/7/2025Q2 2025SKINBeauty Health-$0.06$0.03+$0.09$0.03$74.67 million$78.20 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthOMOutset MedicalN/AN/AN/AN/AN/ASKINBeauty HealthN/AN/AN/AN/AN/ATLSITriSalus Life SciencesN/AN/AN/AN/AN/AVANIVivani MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioOMOutset Medical0.637.476.05SKINBeauty Health4.915.154.15TLSITriSalus Life SciencesN/A4.083.68VANIVivani MedicalN/A1.301.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipOMOutset MedicalN/ASKINBeauty Health93.26%TLSITriSalus Life Sciences2.58%VANIVivani Medical6.78%Insider OwnershipCompanyInsider OwnershipOMOutset Medical2.40%SKINBeauty Health41.00%TLSITriSalus Life Sciences27.50%VANIVivani Medical46.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableOMOutset Medical52017.77 million17.34 millionNot OptionableSKINBeauty Health1,030126.82 million74.83 millionOptionableTLSITriSalus Life Sciences10649.87 million36.15 millionNot OptionableVANIVivani Medical2059.24 million31.76 millionOptionableVANI, SKIN, TLSI, and OM HeadlinesRecent News About These CompaniesVivani Medical Shares Insights at Industry ConferencesSeptember 9 at 5:11 PM | tipranks.comShort Interest in Vivani Medical, Inc. (NASDAQ:VANI) Drops By 32.5%September 9 at 4:28 AM | marketbeat.comShort Interest in Vivani Medical, Inc. (NASDAQ:VANI) Declines By 32.5%September 9 at 2:50 AM | americanbankingnews.comSeptember 2025's Promising Penny Stock OpportunitiesSeptember 6, 2025 | finance.yahoo.comVivani Medical provides update on plans for NPM-139 semaglutide implantSeptember 4, 2025 | msn.comVivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight ManagementSeptember 4, 2025 | globenewswire.comVivani Medical's (VANI) Buy Rating Reiterated at HC WainwrightSeptember 4, 2025 | marketbeat.comA brewing GLP-1 showdown, from Big Pharma pills to a biotech implantAugust 27, 2025 | finance.yahoo.comOzempic for dogs? I’d happily put my food-obsessed golden retriever on ‘Wagovy’August 24, 2025 | aol.comAAre weight-loss jabs for dogs the next big thing? Scientists exploring new solutions for pet obesityAugust 22, 2025 | msn.comOzempic For Pets: New Drug Being Tested For Animal Obesity - Here's What We KnowAugust 22, 2025 | msn.comCould Dogs Get Their Version Of Ozempic? Scientists Test "Ozempup" For Pet ObesityAugust 21, 2025 | ndtv.comNAfter Ozempic, is “Ozempup” on the way? Scientists explore weight-loss jabs for obese pet dogs-- All details hereAugust 21, 2025 | msn.comVivani Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference on Innovative Drug Implant TechnologyAugust 20, 2025 | quiverquant.comQVivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025August 20, 2025 | globenewswire.comFido get fat? Ozempic for dogs could hit the market in three yearsAugust 19, 2025 | msn.comVivani Medical (NASDAQ:VANI) Stock Price Down 0.8% After Earnings MissAugust 15, 2025 | marketbeat.comVivani Medical (NASDAQ:VANI) Announces Quarterly Earnings ResultsAugust 15, 2025 | marketbeat.comVivani closes $10M financing, advances GLP-1 implantAugust 14, 2025 | drugdeliverybusiness.comDVivani Medical, Inc.: Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial ResultsAugust 14, 2025 | finanznachrichten.deVivani Medical Reports Q2 2025 Results and $10M FinancingAugust 13, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVANI, SKIN, TLSI, and OM Company DescriptionsOutset Medical NASDAQ:OM$13.54 -0.65 (-4.58%) Closing price 09/10/2025 04:00 PM EasternExtended Trading$12.97 -0.57 (-4.18%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.Beauty Health NASDAQ:SKIN$2.30 -0.14 (-5.74%) Closing price 09/10/2025 04:00 PM EasternExtended Trading$2.30 0.00 (-0.04%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.TriSalus Life Sciences NASDAQ:TLSI$4.73 -0.17 (-3.47%) Closing price 09/10/2025 04:00 PM EasternExtended Trading$4.73 0.00 (0.00%) As of 09/10/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.Vivani Medical NASDAQ:VANI$1.22 -0.06 (-4.69%) Closing price 09/10/2025 04:00 PM EasternExtended Trading$1.24 +0.02 (+1.23%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle Has Spoken: AI Changes Everything Despite Pullback, Rocket Lab Still Looks Primed for a Breakout Part of the Club: Robinhood & AppLovin Soar on S&P 500 Inclusion Analyst Upgrades Strengthen Microsoft’s Long-Term Outlook Celsius Stock Surges After Blowout Earnings and Pepsi Deal Is Qualcomm Tesla’s Next Rival in Autonomous Driving? Casey’s General Stores: Investors Win With CASY at the Bat Alphabet Stock’s Weakness Was Wall Street’s Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
